Constitution Capital’s AbbVie ABBV Stock Holding History

Constitution Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$209K	Hold	800	–	–	0.1%	61
2026 Q2	$201K	Sell	800 -200	-20%	-$43K	0.1%	62
2026 Q1	$217K	Sell	1,000 -500	-33%	-$111K	0.11%	59
2025 Q4	$343K	Hold	1,500	–	–	0.16%	49
2025 Q3	$347K	Buy	+1,500	New	+$305K	0.16%	49
2025 Q2	–	Sell	-1,000	Closed	-$210K	–	57
2025 Q1	$210K	Buy	+1,000	New	+$194K	0.12%	58
2024 Q1	–	Sell	-2,500	Closed	-$387K	–	61
2023 Q4	$387K	Sell	2,500 -500	-17%	-$72.9K	0.23%	40
2023 Q3	$447K	Hold	3,000	–	–	0.3%	38
2023 Q2	$404K	Hold	3,000	–	–	0.23%	45
2023 Q1	$478K	Sell	3,000 -100	-3%	-$15.3K	0.29%	42
2022 Q4	$501K	Buy	3,100 +400	+15%	+$61.3K	0.31%	41
2022 Q3	$362K	Buy	2,700 +600	+29%	+$86.1K	0.24%	43
2022 Q2	$322K	Hold	2,100	–	–	0.21%	44
2022 Q1	$340K	Buy	2,100 +400	+24%	+$58.1K	0.19%	43
2021 Q4	$230K	Buy	+1,700	New	+$201K	0.12%	59

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Cincinnati Insurance Fairfield, Ohio $6.81B AUM 16.53% 1-Year Est. Return

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $24.1B AUM 30.72% 1-Year Est. Return

Constitution Capital's ABBV Position: Q3 2026 in Review

Constitution Capital held its AbbVie (ABBV) position steady in Q3 2026 at 800 shares worth $209K. The position accounts for 0.1% of the portfolio, ranked #61.

Constitution Capital first reported a position in ABBV in Q4 2021 and has held it in 15 quarters since. The position peaked at $501K in Q4 2022. 2,287 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Constitution Capital held 800 shares of AbbVie worth $209K as of Q3 2026.
Constitution Capital left its AbbVie share count unchanged in Q3 2026.
AbbVie made up 0.1% of Constitution Capital's portfolio in Q3 2026, its #61 holding.
Constitution Capital first reported a position in AbbVie in Q4 2021 and has held it in 15 quarters since.
Constitution Capital's AbbVie position peaked at $501K in Q4 2022.
2,287 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Constitution Capital's 13F filing for Q3 2026, filed 23 Oct 2026.